Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 7/20 | 0.45 |
| ▸ | KIT | P10721 | 2/20 | 0.43 |
| ▸ | FLT3 | P36888 | 2/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 6/20 | 0.43 |
| ▸ | AR | P10275 | 4/20 | 0.41 |
| ▸ | PIM1 | P11309 | 1/20 | 0.41 |
| ▸ | CNR1 | P21554 | 4/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15686371 | 0.85 | CNR2 (0.55) | CNR2KITFLT3FFAR4AR | |
| SCHEMBL20274149 | 0.85 | AR (0.53) | CNR2FFAR4ARCNR1FFAR1 | |
| SCHEMBL946535 | 0.82 | KDR (0.51) | CNR2 | |
| SCHEMBL947373 | 0.82 | KDR (0.51) | CNR2 | |
| SCHEMBL946536 | 0.82 | KDR (0.51) | CNR2 | |
| SCHEMBL15177474 | 0.82 | CNR2 (0.45) | CNR2KITFLT3ARPIM1 | |
| SCHEMBL13158252 | 0.82 | MAPK1 (0.45) | CNR2FFAR4ARCNR1FFAR1 | |
| SCHEMBL945211 | 0.80 | PIM1 (0.44) | CNR2KITFLT3ARPIM1 | |
| SCHEMBL945523 | 0.80 | PIM1 (0.44) | CNR2KITFLT3ARPIM1 | |
| SCHEMBL945213 | 0.80 | PIM1 (0.44) | CNR2KITFLT3ARPIM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120094981-A1 | ANTHELMINTIC AGENTS AND THEIR USE | INTERVET INTERNATIONAL B.V. (NL) | 2012-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120094981-A1 | ANTHELMINTIC AGENTS AND THEIR USE | ABCB11, ACHE, CMA1 | CNR2 597/4885KIT 24/4885FLT3 1398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.